What is she best known for?
The fields of study she is best known for:
Her scientific interests lie mostly in Cancer research, Genetics, Germline mutation, Mutation and Birt–Hogg–Dubé syndrome.
Her research integrates issues of Cancer, Endocrinology, Kidney, DNA methylation and PBRM1 in her study of Cancer research.
As part of one scientific family, Laura S. Schmidt deals mainly with the area of Kidney, narrowing it down to issues related to the Carcinoma, and often Loss of heterozygosity and Renal cell carcinoma.
Her Germline mutation research integrates issues from Genome, Aneuploidy and Germline.
The study incorporates disciplines such as Respiratory disease, Folliculin and Pathology in addition to Birt–Hogg–Dubé syndrome.
Her studies in Clear cell renal cell carcinoma integrate themes in fields like SETD2, Chromatin, microRNA, CDKN2A and Signal transduction.
Her most cited work include:
- Comprehensivemolecular characterization of clear cell renal cell carcinoma (1909 citations)
- Comprehensivemolecular characterization of clear cell renal cell carcinoma (1909 citations)
- Mutations of the VHL tumour suppressor gene in renal carcinoma (1437 citations)
What are the main themes of her work throughout her whole career to date?
Laura S. Schmidt mainly investigates Cancer research, Folliculin, Pathology, Genetics and Cancer.
Her study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Germline mutation, Kidney cancer, Tumor suppressor gene and Kidney.
Her studies deal with areas such as Molecular biology, AMPK, Birt–Hogg–Dubé syndrome, Cell biology and PI3K/AKT/mTOR pathway as well as Folliculin.
The Pathology study combines topics in areas such as Lung and Hereditary leiomyomatosis and renal cell carcinoma.
Her study on Cancer also encompasses disciplines like
- Renal cell carcinoma which connect with Carcinoma, TSC1 and BAP1,
- Oncology, which have a strong connection to Targeted therapy.
Her work in Clear cell renal cell carcinoma addresses subjects such as Chromatin, which are connected to disciplines such as microRNA and DNA methylation.
She most often published in these fields:
- Cancer research (61.93%)
- Folliculin (39.77%)
- Pathology (35.23%)
What were the highlights of her more recent work (between 2017-2021)?
- Cancer research (61.93%)
- Renal cell carcinoma (24.43%)
- Folliculin (39.77%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Cancer research, Renal cell carcinoma, Folliculin, Transcription factor and Gene.
Her Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Germline mutation, Carcinogenesis, Kidney cancer and TFE3.
Laura S. Schmidt has included themes like Cell, BAP1, Kidney and Cancer genome in her Renal cell carcinoma study.
Her Folliculin study combines topics in areas such as Tumor suppressor gene, GTPase and Birt–Hogg–Dubé syndrome.
The concepts of her Transcription factor study are interwoven with issues in microRNA and Cell biology.
Her work deals with themes such as Transforming growth factor beta and Signal transduction, which intersect with Gene.
Between 2017 and 2021, her most popular works were:
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (293 citations)
- Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060)) (147 citations)
In her most recent research, the most cited papers focused on:
Laura S. Schmidt mainly focuses on Cancer research, microRNA, Gene, Renal cell carcinoma and Germline mutation.
Her Cancer research study combines topics from a wide range of disciplines, such as Transcription factor, Oncogene, Chromatin, Birt–Hogg–Dubé syndrome and Folliculin.
Laura S. Schmidt works mostly in the field of microRNA, limiting it down to topics relating to DNA methylation and, in certain cases, HMGA2, Mutation rate, Signal transduction and Transforming growth factor beta, as a part of the same area of interest.
Her work in the fields of Gene, such as Missense mutation, intersects with other areas such as Characterization and Statistical analysis.
Her Renal cell carcinoma research incorporates elements of Cell, BAP1, Computational biology and Cancer genome.
Part of her project on Germline mutation includes research on Genetics and Mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
